Scarica l'app Stockscreener
53.26
2.74%
-1.50
Dopo l'orario di chiusura:
53.26
Precedente Chiudi:
$54.76
Aprire:
$54.86
Volume 24 ore:
243.19K
Relative Volume:
0.52
Capitalizzazione di mercato:
$1.12B
Reddito:
$1.77M
Utile/perdita netta:
$-123.74M
Rapporto P/E:
-5.8081
EPS:
-9.17
Flusso di cassa netto:
$-95.21M
1 W Prestazione:
-2.06%
1M Prestazione:
+32.39%
6M Prestazione:
+87.07%
1 anno Prestazione:
-14.06%
Intervallo 1D:
$51.99
$55.10
Intervallo di 1 settimana:
$50.31
$55.79
Portata 52W:
$26.70
$91.83
Praxis Precision Medicines Inc Stock (PRAX) Company Profile
Nome
Praxis Precision Medicines Inc
Settore
Industria
Telefono
617-300-8460
Indirizzo
99 HIGH STREET, 30TH FLOOR, BOSTON
Confronta PRAX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
PRAX
Praxis Precision Medicines Inc
|
53.26 | 1.15B | 1.77M | -123.74M | -95.21M | -9.17 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.79 | 106.37B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
460.46 | 59.90B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
564.63 | 60.40B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
796.92 | 49.56B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.10 | 36.88B | 4.56B | -176.77M | 225.30M | -1.7177 |
Praxis Precision Medicines Inc Stock (PRAX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-06-02 | Ripresa | Oppenheimer | Outperform |
| 2025-05-07 | Iniziato | Chardan Capital Markets | Buy |
| 2025-03-03 | Reiterato | H.C. Wainwright | Buy |
| 2025-02-11 | Iniziato | Deutsche Bank | Buy |
| 2024-08-05 | Iniziato | Oppenheimer | Outperform |
| 2024-06-24 | Iniziato | Needham | Buy |
| 2024-06-18 | Iniziato | Guggenheim | Buy |
| 2024-05-01 | Iniziato | Robert W. Baird | Outperform |
| 2023-09-19 | Iniziato | Truist | Buy |
| 2022-06-06 | Downgrade | Wedbush | Outperform → Neutral |
| 2021-12-16 | Iniziato | H.C. Wainwright | Buy |
| 2021-08-26 | Iniziato | BofA Securities | Buy |
| 2021-04-26 | Iniziato | William Blair | Outperform |
| 2020-11-11 | Iniziato | Wedbush | Outperform |
| 2020-11-10 | Iniziato | Cowen | Outperform |
| 2020-11-10 | Iniziato | Evercore ISI | Outperform |
| 2020-11-10 | Iniziato | Piper Sandler | Overweight |
Mostra tutto
Praxis Precision Medicines Inc Borsa (PRAX) Ultime notizie
Multi asset correlation models including Praxis Precision Medicines Inc.Weekly Earnings Recap & Safe Entry Momentum Tips - newser.com
Praxis Precision Medicines (NASDAQ:PRAX) Receives Sell (D-) Rating from Weiss Ratings - MarketBeat
How institutional ownership impacts Praxis Precision Medicines Inc. stockExit Point & Verified High Yield Trade Plans - newser.com
Price momentum metrics for Praxis Precision Medicines Inc. explainedTrend Reversal & Verified Technical Signals - newser.com
Did the ReCode Partnership Just Shift Praxis Precision Medicines' (PRAX) Innovation Narrative in Neuroscience? - Yahoo Finance
Assessing Praxis Precision Medicines (PRAX) Valuation After Recent Share Price Momentum - Yahoo
Why Praxis Precision Medicines Inc. is moving todayJuly 2025 Outlook & AI Powered Trade Plan Recommendations - newser.com
Published on: 2025-10-06 01:53:19 - newser.com
Praxis Precision Medicines, Inc. (NASDAQ:PRAX) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
Is Praxis Precision Medicines Inc a good long term investmentOptions Trading Strategies & Minimal Capital Growth Plans - earlytimes.in
Visual analytics tools that track Praxis Precision Medicines Inc. performance2025 Market Trends & Growth Focused Stock Pick Reports - newser.com
Real time pattern detection on Praxis Precision Medicines Inc. stockTreasury Yields & Daily Oversold Stock Bounce Ideas - newser.com
Praxis Precision Medicines Inc. stock trend forecastQuarterly Profit Report & Free Weekly Watchlist of Top Performers - newser.com
Praxis Precision Medicines (PRAX): Evaluating Valuation Potential Following Brain-Targeted Delivery Collaboration - Sahm
Is Praxis Precision Medicines Inc. stock undervalued vs historical averagesJuly 2025 Momentum & Low Risk Investment Opportunities - newser.com
Real time scanner hits for Praxis Precision Medicines Inc. explainedQuarterly Growth Report & Real-Time Market Sentiment Reports - newser.com
What technical models suggest about Praxis Precision Medicines Inc.’s comebackGap Up & Consistent Profit Focused Trading Strategies - newser.com
Could PRAX's Focus on Delivery Innovation Signal a Shift in CNS Therapy Ambitions? - Sahm
Chart based analysis of Praxis Precision Medicines Inc. trendsJuly 2025 EndofMonth & Intraday High Probability Alerts - newser.com
Will earnings trigger a reversal in Praxis Precision Medicines Inc.July 2025 Institutional & High Accuracy Buy Signal Tips - newser.com
Published on: 2025-10-02 21:58:13 - newser.com
Risk vs reward if holding onto Praxis Precision Medicines Inc.July 2025 Snapshot & Stepwise Entry/Exit Trade Alerts - newser.com
Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
Praxis Precision Medicines announces inducement grants under Nasdaq Listing Rule - MarketScreener
4,200 RSUs: Praxis Precision Medicines Grants Awards to 3 New Hires, Vesting Over 4 Years - Stock Titan
Piper Sandler reiterates Overweight rating on Praxis Precision Medicines stock - Investing.com
Published on: 2025-10-01 08:22:08 - newser.com
Published on: 2025-09-30 15:59:01 - newser.com
Should You Stay Invested in Aspinwall and Company Limited for the Long HaulStock Buyback Announcements & Affordable Trading Plans - earlytimes.in
ReCode Therapeutics Announces Over $29 Million in Additional Financing to Advance Genetic Medicines Pipeline and Provides Corporate Update - Business Wire
Praxis Precision Medicines Inc Azioni (PRAX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Praxis Precision Medicines Inc Azioni (PRAX) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Nemiroff Alex | General Counsel and Secretary |
Nov 14 '24 |
Option Exercise |
56.94 |
7,583 |
431,776 |
18,540 |
| Nemiroff Alex | General Counsel and Secretary |
Nov 14 '24 |
Sale |
80.20 |
8,239 |
660,827 |
10,301 |
| Mastrocola Lauren | Principal Accounting Officer |
Nov 14 '24 |
Option Exercise |
56.94 |
4,374 |
249,056 |
10,801 |
| Mastrocola Lauren | Principal Accounting Officer |
Nov 14 '24 |
Sale |
81.78 |
5,188 |
424,318 |
5,613 |
5.74%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):